Erin E. Mulvihill

Jan 7, 2025 | cell.com | Jessica D. Ewald |Yao Lu |Cara E. Ellis |Jessica Worton |Jelena Kolic |Shugo Sasaki | +25 more

ForumVolume 37, Issue 1p7-11 1Institute of Parasitology, McGill University, Montreal, QC, Canada 2Imaging Platform, Broad Institute of MIT and Harvard, Cambridge, MA, USA 3Alberta Diabetes Institute, University of Alberta, Edmonton, AB, Canada 4Department of Pharmacology, University of Alberta, Edmonton, AB, Canada 5Department of Surgery, University of Alberta, Edmonton, AB, Canada 6Department of Cellular and Physiological Sciences, Life Sciences Institute, University of British Columbia,...

Jan 7, 2025 | cell.com | Jessica D. Ewald |Yao Lu |Cara E. Ellis |Jessica Worton |Jelena Kolic |Shugo Sasaki | +25 more

ForumVolume 37, Issue 1p7-11 1Institute of Parasitology, McGill University, Montreal, QC, Canada 2Imaging Platform, Broad Institute of MIT and Harvard, Cambridge, MA, USA 3Alberta Diabetes Institute, University of Alberta, Edmonton, AB, Canada 4Department of Pharmacology, University of Alberta, Edmonton, AB, Canada 5Department of Surgery, University of Alberta, Edmonton, AB, Canada 6Department of Cellular and Physiological Sciences, Life Sciences Institute, University of British Columbia,...

Nov 14, 2024 | biorxiv.org | Sarah Hewko |Kaarina Kowalec |Laura Anderson |Erin E. Mulvihill

AbstractIntroduction: The COVID-19 pandemic disrupted research globally. How it impacted Canadian early-career health researchers (ECHRs) remains unclear. We administered a survey to understand the composition of ECHRs in Canada, their job experiences, and experiences of burnout during the COVID-19 pandemic. Methods: A cross-sectional survey was conducted in May 2023 of Canadian ECHRs defined as within 7 years of their first independent research position.

Sep 19, 2024 | joe.bioscientifica.com | Neerav Mullur |Arianne Morissette |Nadya M. Morrow |Erin E. Mulvihill

Figure 1 Cardiovascular benefits of GLP-1RA, dual, or triple agonists. (A) Distribution of (in black), or (in blue), and or (in green) mRNA in the heart of humans and mice. (B) Mechanisms of action by which GLP-1RA (black), dual (blue), or triple agonists (green) improve cardiovascular outcomes.

Apr 30, 2024 | mdpi.com | Léa Garneau |Erin E. Mulvihill |Steven Smith |Lauren M. Sparks

All articles published by MDPI are made immediately available worldwide under an open access license. No specialpermission is required to reuse all or part of the article published by MDPI, including figures and tables. Forarticles published under an open access Creative Common CC BY license, any part of the article may be reused withoutpermission provided that the original article is clearly cited. For more information, please refer tohttps://www.mdpi.com/openaccess.